Phoenix Technology Group Announces the Appointment of its Clinical Advisory Board
Advisory Board of leading physicians and ophthalmic photographers appointed to set
strategic direction for the Phoenix ICON product line.
Pleasanton, CA – October 30, 2017: Phoenix Technology Group (PTG) today announced the formation of the new Clinical Advisory Board (CAB), made up of leading physicians and ophthalmic photographers. The CAB brings diverse and relevant areas of expertise to PTG to help inform future strategic development of the company’s clinical products, including innovation priorities and clinical direction for the Phoenix ICON product line, the leading wide-view retinal imaging platform.
“Phoenix’s success has been built on our commitment to contribute to winning the war on blindness through innovation in imaging platforms” said Bert Massie, Ph.D., Phoenix founder and chairman of the board. “The launch of our Clinical Advisory Board continues that commitment. We selected CAB members with a broad range of medical, clinical and research expertise, and I couldn’t be more excited about the ways this group will help focus on innovation and product priorities.”
Members of the Clinical Advisory Board include:
Audina Berrocal, M.D.
Susmito Biswas, MB BS, FRCOphth
Sandor Ferenczy, CRA, OCTc
Ed Guthrie, M.D.
Domenico Lepore, M.D.
Eric Nudleman, M.D., Ph.D.
Michael Trese, M.D.
Building on the company’s ongoing commitment to patient- and physician-driven innovation, Phoenix will hold twice yearly summits for the Clinical Advisory Board. The first CAB summit is scheduled to occur at the annual American Academy of Ophthalmologists meeting in November.
The CAB will initially focus on:
Prioritizing the development of imaging modalities and image processing enhancements
Taking advantage of the rise in the use of telemedicine to provide rapid access to diagnostic screening
Effective integration with centralized and distributed medical information systems to support information sharing and longitudinal patient assessment
Exploring additional technological, product, and platform improvements to Phoenix Technology Group’s current offerings
J. Scott Carr, Phoenix CEO, will work closely with Dr. Massie and the CAB. “We are fortunate to benefit from such an outstanding group of advisors, and look forward to learning from their strategic input as we continue to innovate products to see and understand the eye,” said Carr. “Their enthusiasm for our mission has been one of the most rewarding elements of this process as well as their excitement to see their ideas come to life in our products.”
About Phoenix Technology Group: Phoenix Technology Group (PTG) contributes to the fight to prevent blindness by providing physicians, clinicians, and researchers around the world with advanced technology to image and understand the eye. Founded by Bert Massie, Ph.D., inventor of the first digital camera for pediatric retinal imaging, our journey began with the creation of the Phoenix MICRON platform for in-vivo imaging of animals in eye research. Today, the MICRON platform is the standard for researchers around the world, combining bright field imaging, image-guided OCT, and focal and Ganzfeld ERG. Our breakthrough innovations with the Phoenix MICRON platform led to us to reinvent wide-field retinal imaging for human clinical applications, resulting in the recently launched Phoenix ICON product line. The ICON platform is a revolutionary retinal imaging platform delivering high-contrast, high-resolution images, with quality you can see. You’ll find these breakthroughs inside the ICON platform: completely reinvented illumination, optics, and sensor technology, deployed on a modular platform that was designed from the ground-up for ease of use, reliability, and incredible image quality.
Contact: Jen King, Phoenix Technology Group, ph.1.925.485.1100,